Table III.
Predictive factors for the final WOMAC score
| Variables | B | β | t | P | F | Adapted R2 |
|---|---|---|---|---|---|---|
| Female | −1.180 | −0.032 | −0.276 | 0.783 | 3.581 | 0.451 |
| Age | −0.377 | −0.122 | −0.977 | 0.332 | ||
| Height | 1.277 | 0.898 | 1.869 | 0.066 | ||
| Weight | −1.793 | −1.176 | −1.324 | 0.190 | ||
| BMI | 4.113 | 0.848 | 1.310 | 0.194 | ||
| Left side | 3.671 | 0.124 | 1.271 | 0.208 | ||
| Comorbidity | 4.379 | 0.084 | 0.801 | 0.426 | ||
| Treatment history | 1.005 | 0.031 | 0.315 | 0.754 | ||
| Hartofilakidis Type III | 3.225 | 0.106 | 1.032 | 0.305 | ||
| Pre-operative femoral anteversion | −0.205 | −0.182 | −1.414 | 0.161 | ||
| Combined with femoral osteotomy | 2.251 | 0.050 | 0.391 | 0.697 | ||
| Post-operative femoral anteversion | 0.474 | 0.184 | 1.736 | 0.087 | ||
| Capsular quality | −2.737 | −0.093 | −0.869 | 0.388 | ||
| Capsular thickness | −6.485 | −0.446 | −3.968 | <0.001 | ||
| Mean femoral head diameter | −0.645 | −0.228 | −1.772 | 0.041 | ||
| New socket diameter | −0.748 | −0.291 | −2.231 | 0.029 | ||
| Follow-up time | 0.016 | 0.024 | 0.253 | 0.801 |
The bold-faced entries indicate statistically significant results.